E80.21

Clinical Causes: Inherited genetic mutation affecting the enzymes involved in heme production. Exposure to certain medications such as barbiturates, sulfonamides, or hormonal contraceptives. Alcohol consumption and smoking can trigger episodes. Fasting or dieting that leads to reduced caloric intake. Infections or stress that increase the body's need for heme production.

Key Symptoms: Severe abdominal pain lasting hours to days. Portion of the abdomen sensitive to touch. Nausea and vomiting. Muscle weakness and cramps. Psychological symptoms like anxiety, confusion, or hallucinations. Dark or reddish urine during episodes due to excess porphyrins. Tingling or numbness in the extremities.

Diagnosis Path: Diagnosis involves a combination of medical history, physical examination, and laboratory tests. Elevated levels of porphyrin precursors such as delta-aminolevulinic acid (ALA) and porphobilinogen (PBG) in urine are key indicators. Blood and stool tests may also assist in confirming the diagnosis. Genetic testing can determine specific mutations associated with the condition.

Treatment Protocols: While there is no cure for acute intermittent hepatic porphyria, management aims to reduce the severity and frequency of attacks. During episodes, hospitalization may be required to administer intravenous glucose and heme injections, which can help suppress porphyrin production. Patients are advised to avoid known triggers, including certain medications, alcohol, fasting, and stress. Long-term management may include regular monitoring and medication adjustments to prevent attacks and manage symptoms.